Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for pediatric gastroscopy sedation
ChiCTR2100041686Phase 4Recruiting
- Sponsor
- Kunming Children's Hospital
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in esophagogastroduodenoscopy (2 arms), sponsored by Kunming Children's Hospital. Primary endpoint: Success rate of gastroscopy. Started Jan 2021; status: recruiting.
02
Drugs
remimazolam
03
Conditions
esophagogastroduodenoscopy
Beyond the preview
Go deeper on ChiCTR2100041686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100041686.